VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 403 filers reported holding VANECK VECTORS ETF TR in Q3 2018. The put-call ratio across all filers is 1.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $825,000 | -15.4% | 34,185 | -4.0% | 0.04% | -14.6% |
| Q2 2022 | $975,000 | -49.8% | 35,624 | -29.4% | 0.04% | -45.3% |
| Q1 2022 | $1,944,000 | +53.2% | 50,487 | +26.3% | 0.08% | +27.1% |
| Q4 2021 | $1,269,000 | +3.3% | 39,980 | -3.5% | 0.06% | -1.7% |
| Q3 2021 | $1,228,000 | -54.3% | 41,410 | -47.6% | 0.06% | -50.8% |
| Q2 2021 | $2,688,000 | +58.1% | 79,102 | +51.2% | 0.12% | +37.1% |
| Q1 2021 | $1,700,000 | -2.2% | 52,312 | +8.4% | 0.09% | -4.3% |
| Q4 2020 | $1,738,000 | +110.7% | 48,238 | +129.0% | 0.09% | +36.8% |
| Q3 2020 | $825,000 | +160.3% | 21,067 | +48.1% | 0.07% | +21.4% |
| Q2 2018 | $317,000 | +42.8% | 14,225 | +40.8% | 0.06% | +300.0% |
| Q1 2018 | $222,000 | -12.6% | 10,104 | -7.7% | 0.01% | -48.1% |
| Q4 2017 | $254,000 | -12.7% | 10,949 | -0.7% | 0.03% | -34.1% |
| Q3 2016 | $291,000 | – | 11,025 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |